Nashville Children’s Hospital Seeing Numerous Cases of MIS-C in Children with COVID-19 History
Pediatricians at the Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville have detected five cases of multi-inflammatory syndrome in children (MIS-C) since mid-July. The condition is considered to be associated with COVID-19, with 90 percent of children with MIS-C diagnoses also having COVID-19 symptoms or had them in the past. However, researchers are at [ ]
Pediatricians at the Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville have detected five cases of multi-inflammatory syndrome in children (MIS-C) since mid-July.The condition is considered to be associated with COVID-19, with 90 percent of children with MIS-C diagnoses also having COVID-19 symptoms or had them in the past. However, researchers are at a loss as to how the correlation develops. In pre-COVID-19 times, only 2 out of 100,000 people under the age of 21 developed MIS-C; however, with the novel coronavirus coming into play, the figure is 322 per 100,000 people under the age of 21.MIS-C symptoms typically emerge between two and four weeks after COVID-19 infection. Some common symptoms are: fever, neck pain, rash, bloodshot eyes, swelling of hands and feet, fatigue, stomach pain, and vomiting. In severe cases, a child might have trouble breathing or suffer from chest pain. ReferencesWhittaker E, Bamford A, Kenny J, et al. "Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Related to SARS-CoV-2." JAMA Pediatrics. 2020;174(5):e2020031. DOIBritish Journal of Dermatology. 2020;183(3):614-619. DOILu F, Hsieh Y, Wang Y, et al. "Multisystem inflammatory syndrome in children and COVID-19: A systematic review." Journal of the American Academy of Dermatology. 2021;84(3):674-679. DOISharma A, Kaur M, Bansal S, et al. "The emergence of multisystem inflammatory syndrome in children in the context of COVID-19." Journal of Investigative Dermatology. 2021;141(6):1475-1480. DOIMcCrindle BW, Rowley AH, Newburger JW, et al. "COVID-19 and Kawasaki Disease: What We Know and Don't Know." New England Journal of Medicine. 2021;385(9):847-857. DOI